Hasan Üstün

Assoc. Prof. Hasan Üstün is a medical oncologist with a medical degree from Dokuz Eylul University Faculty of Medicine, class of 1999. He holds the academic title of Associate Professor and has been practicing in clinical oncology for over two decades. Since 2020 he has been affiliated with Acibadem Health Group, where he provides patient-centered cancer care, participates in multidisciplinary teams, and contributes to clinical practice and education. Known for a calm, professional approach, he combines evidence-based treatment with compassionate communication to support patients and families through diagnosis, treatment, and survivorship.

Education

• 1999 Dokuz Eylul University Faculty of Medicine Medical Oncology
• 1996 Akdeniz University Faculty of Medicine Internal Medicine
• 1991 Hacettepe University Faculty of Medicine

Experience

• 2020 Acibadem Health Group
• 2013 – 2015 Eskisehir Private Sakarya Hospital
• 2011 – 2013 Eskisehir Osmangazi Karaelmas University Faculty of Medicine Department of Internal Medicine Division of Medical Oncology
• 2010 – 2011 Zonguldak Karaelmas University Faculty of Medicine Department of Internal Medicine Division of Medical Oncology
• 2007 – 2009 Eskilstuna Teaching Hospital Oncology Department Eskilstuna / Sweden
• 2005 – 2007 Department of Oncology, Karolinska University Stockholm / Sweden
• 1999 – 2002 Kocaeli University Faculty of Medicine Department of Internal Medicine

Publications

• ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region
  Asian Pac J Cancer Prev. 13(1 ):131-3 (2012). Engin H, Bilir C, Üstün H, Gökmen A.
• In vitro effect of radiation, antibody to epidermal growth factor receptor and Docetaxel in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR
  J Cancer Res Clin Oncol. 135(2):203-9 (2009) Laytragoon-Lewin N, Ustun H, Castro J, Friesland S, Ghaderi M, Lundgren J, Turesson I, Lewin F
• Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
  Adv Ther. 25(10):1075-84 (2008) Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M
• Effects of vitamin A on doxorubicin-induced chromosomal aberrations in bone marrow cells of rats.
  Mutagenesis, 19, 231-236 (2004). Gulkac MD, Akpinar G, Ustun H, Ozone Kanli A.
• Effects of 10alpha,25-dihydroxyvitamin D3 on doxorubicin-induced chromosomal aberrations in rat bone marrow cells.
  Acta Oncol, 43, 204-208 (2004). Koçak N, Ustun H, Gulkac MD, Kanli AO, Borazan A, Yilmaz A.
• The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
  Mediators Inflamm, 13, 201-204 (2004). Borazan A, Ustun H, Ustundag Y, Aydemir S, Bayraktaroglu T, Sert M, Yilmaz A
• Pure nongestational choriocarcinoma of ovary.
  Arch Gynecol Obstet. 2004 Feb 28. Corakci A, Ozeren S, Ozkan S, Gurbuz Y, Ustun H, Yucesoy I.
• Primary non-Hodgkin lymphoma of skeletal muscle coexistence with cutaneous infiltration.
  Acta Medica (Hradec Kralove), 46, 213-214 (2003). Borazan A, Ustun H, Ecirli S.
• Clinical assessment of 324 breast cancer cases in two centers between the years of 1992 and 2002
  Acta Medica (Hradec Kralove), 46, 195-199 (2003). Borazan A, Ustun H, Aksoy F, Vatansev C, Canturk Z, Akkas M, Ecirli S, Yilmaz A
• Comparative efficacy of oral and intravenous calcitriol treatment in haemodialysis patients: effects on serum biochemistry and cytokine evels.
  J Int Med Res, 31, 489-496 (2003). Borazan A, Ustun H, Cefle A, Sekitmez N, Yilmaz A.